Recent studies examined sleep and the consequences of sleep disruption in the PS19 mouse model of AD/FTD that expresses an aggregation-prone human Tau P301S variant (Yoshiyama et al., 2007). This evidence concerns the gene MAPT and Alzheimer disease.